224 related articles for article (PubMed ID: 32187960)
1. Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma.
Lei W; Wang S; Xu N; Chen Y; Wu G; Zhang A; Chen X; Tong Y; Qian W
Biomed Pharmacother; 2020 May; 125():110030. PubMed ID: 32187960
[TBL] [Abstract][Full Text] [Related]
2. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
Tong Y; You L; Liu H; Li L; Meng H; Qian Q; Qian W
Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
[TBL] [Abstract][Full Text] [Related]
3. Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.
Xie S; Fan W; Yang C; Lei W; Pan H; Tong X; Wu Y; Wang S
Oncol Rep; 2021 Mar; 45(3):987-996. PubMed ID: 33469679
[TBL] [Abstract][Full Text] [Related]
4. Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma.
Lei W; Wang S; Yang C; Huang X; Chen Z; He W; Shen J; Liu X; Qian W
Sci Rep; 2016 Aug; 6():32174. PubMed ID: 27552933
[TBL] [Abstract][Full Text] [Related]
5. Engineering oncolytic vaccinia virus with functional peptides through mild and universal strategy.
Huang LL; Li X; Liu K; Zou B; Xie HY
Anal Bioanal Chem; 2019 Feb; 411(4):925-933. PubMed ID: 30523361
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.
Deng H; Tang N; Stief AE; Mehta N; Baig E; Head R; Sleep G; Yang XZ; McKerlie C; Trudel S; Stewart AK; McCart JA
Leukemia; 2008 Dec; 22(12):2261-4. PubMed ID: 18509356
[No Abstract] [Full Text] [Related]
7. An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy.
Wang S; Li Y; Xu C; Dong J; Wei J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458640
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
[TBL] [Abstract][Full Text] [Related]
9. Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer.
Sun F; Guo ZS; Gregory AD; Shapiro SD; Xiao G; Qu Z
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461344
[TBL] [Abstract][Full Text] [Related]
10. Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.
Marchica V; Franceschi V; Vescovini R; Storti P; Vicario E; Toscani D; Zorzoli A; Airoldi I; Dalla Palma B; Campanini N; Martella E; Mancini C; Costa F; Donofrio G; Giuliani N
J Hematol Oncol; 2020 Jul; 13(1):89. PubMed ID: 32653014
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review.
Li M; Zhang M; Ye Q; Liu Y; Qian W
Cancer Biol Med; 2023 Aug; 20(9):646-61. PubMed ID: 37615308
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer.
Horita K; Kurosaki H; Nakatake M; Ito M; Kono H; Nakamura T
Biochem Biophys Res Commun; 2019 Aug; 516(3):831-838. PubMed ID: 31262449
[TBL] [Abstract][Full Text] [Related]
13. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
Deng L; Fan J; Guo M; Huang B
Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
[TBL] [Abstract][Full Text] [Related]
15. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
Kurosaki H; Nakatake M; Sakamoto T; Kuwano N; Yamane M; Ishii K; Fujiwara Y; Nakamura T
Cells; 2021 Apr; 10(5):. PubMed ID: 33922406
[TBL] [Abstract][Full Text] [Related]
17. CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma.
Lei W; Ye Q; Hao Y; Chen J; Huang Y; Yang L; Wang S; Qian W
Blood Cancer J; 2022 Feb; 12(2):35. PubMed ID: 35228544
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer.
Chen W; Fan W; Ru G; Huang F; Lu X; Zhang X; Mou X; Wang S
Oncol Rep; 2019 Jan; 41(1):67-76. PubMed ID: 30365143
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in combination therapy of oncolytic vaccinia virus.
Mirbahari SN; Da Silva M; Zúñiga AIM; Kooshki Zamani N; St-Laurent G; Totonchi M; Azad T
Front Immunol; 2024; 15():1272351. PubMed ID: 38558795
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
